What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs
-
* Corresponding author: R Andrew Moore andrew.moore@pru.ox.ac.uk
Arthritis Research & Therapy 2008, 10:R20 doi:10.1186/ar2373
Accesses
- Last 30 days: 95 accesses
- Last year: 1364 accesses
- All time: 13826 accesses
Cited by
BioMed Central: 2 citations
|
Research article
Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use Sebastian Straube, Martin R Tramèr, R Andrew Moore, Sheena Derry, Henry J McQuay BMC Gastroenterology 2009, 9:41 (5 June 2009) |
|
Research article
R Andrew Moore, Owen A Moore, Sheena Derry, Henry J McQuay Arthritis Research & Therapy 2008, 10:R39 (2 April 2008) |